HQH:NYE-Tekla Healthcare Investors (USD)

ETF | Asset Management | New York Stock Exchange

Last Closing

USD 16.19

Change

-0.27 (-1.64)%

Market Cap

USD 0.90B

Volume

0.36M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

To achieve long-term capital appreciation by investing at least 80% of its assets in securities of health services and medical technology companies. The Trust may invest up to 20% of its net assets in non-US securities and up to 40% in venture capital or other securities subject to legal or contractual restrictions as to resale.

Inception Date: 23/04/1987

Primary Benchmark: NASDAQ Biotechnology TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 1.03%

Management Expense Ratio:

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-30 )

Largest Industry Peers for Asset Management

Symbol Name Mer Price(Change) Market Cap
BX Blackstone Group Inc 0.00 %

+1.33 (+0.77%)

USD 207.21B
BLK BlackRock Inc 0.00 %

-7.71 (-0.75%)

USD 161.52B
KKR KKR & Co LP 0.00 %

+1.28 (+0.87%)

USD 136.19B
APO Apollo Global Management LLC C.. 0.00 %

+0.70 (+0.42%)

USD 100.63B
BN Brookfield Corp 0.00 %

+0.10 (+0.17%)

USD 91.05B
ARES Ares Management LP 0.00 %

+1.80 (+1.02%)

USD 55.11B
AMP Ameriprise Financial Inc 0.00 %

-2.47 (-0.46%)

USD 54.48B
OWL Blue Owl Capital Inc 0.00 %

+0.33 (+1.42%)

USD 36.40B
RJF Raymond James Financial Inc. 0.00 %

-0.33 (-0.21%)

USD 32.02B
BAM Brookfield Asset Management In.. 0.00 %

+0.15 (+0.28%)

USD 24.37B

ETFs Containing HQH

FCEF First Trust Income Opport.. 0.00 % 0.85 %

-0.07 (0.69%)

USD 0.04B
YYY Amplify High Income ETF 0.00 % 0.50 %

+0.08 (+0.69%)

USD 0.54B

Market Performance

  Market Performance vs. Industry/Classification (Asset Management) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.29% 22% F 31% F
Dividend Return 10.02% 81% B- 93% A
Total Return 7.72% 40% F 50% F
Trailing 12 Months  
Capital Gain -2.29% 22% F 31% F
Dividend Return 10.02% 81% B- 93% A
Total Return 7.72% 40% F 50% F
Trailing 5 Years  
Capital Gain -22.46% 46% F 25% F
Dividend Return 42.66% 86% B+ 94% A
Total Return 20.20% 64% D 49% F
Average Annual (5 Year Horizon)  
Capital Gain -2.35% 45% F 22% F
Dividend Return 6.28% 61% D- 47% F
Total Return 8.64% 90% A- 95% A
Risk Return Profile  
Volatility (Standard Deviation) 19.58% 66% D+ 56% F
Risk Adjusted Return 32.08% 66% D+ 47% F
Market Capitalization 0.90B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector